A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Endostatin is a potent endogenous angiogenic inhibitor with implicated antitumor activity. However, efficacy of recombinant human endostatin (rhES) in clinical trials is controversial, and application of rhES in treatment of metastatic melanoma awaits further investigations. This phase II trial eval...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cui, Chuanliang, Mao, Lili, Chi, Zhihong, Si, Lu, Sheng, Xinan, Kong, Yan, Li, Siming, Lian, Bin, Gu, Kangsheng, Tao, Min, Song, Xin, Lin, Tongyu, Ren, Xiubao, Qin, Shukui, Guo, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3702105/
https://ncbi.nlm.nih.gov/pubmed/23670576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2013.79
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados